Morgan Stanley’s Inhibrx, Inc. Common Stock INBX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $19.2M | Sell |
|
|||||
|
2023
Q4 | $22.6M | Buy |
|
|||||
|
2023
Q3 | $7.02M | Sell |
|
|||||
|
2023
Q2 | $9.99M | Buy |
|
|||||
|
2023
Q1 | $7.1M | Buy |
|
|||||
|
2022
Q4 | $6.33M | Buy |
|
|||||
|
2022
Q3 | $2.89M | Buy |
|
|||||
|
2022
Q2 | $1.59M | Sell |
|
|||||
|
2022
Q1 | $6.34M | Buy |
|
|||||
|
2021
Q4 | $2.46M | Buy |
|
|||||
|
2021
Q3 | $108K | Sell |
|
|||||
|
2021
Q2 | $724K | Sell |
|
|||||
|
2021
Q1 | $707K | Buy |
|
|||||
|
2020
Q4 | $203K | Buy |
|